MicroVision stock heads into October 7 business update

Published on 10/05/2026 at 19:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MicroVision stock was trading at USD 1.46 on October 5, 2026, while Q2 revenue reached USD 1.47 million. Management's October 7 update will address commercial progress and cash use.

MVIS, US5949604038, Illustration mit AI erstellt.

MicroVision stock (ISIN US5949604038) was trading at USD 1.46 on Nasdaq on October 5, 2026, at 1:19 p.m. ET, down 1.35 percent from the previous close. The company is preparing a business update that will give investors a closer look at commercialization, revenue expectations and operating costs.

October 7 update sets the next checkpoint

According to MicroVision on October 2, 2026, the video session will begin on October 7, 2026, at 4:00 p.m. ET. CEO Glen DeVos, CFO Christine Chambers and Chief Commercial Officer James Byun are scheduled to discuss commercial progress, revenue and operating expense expectations, and the business outlook.

The session also provides context for the third-quarter 2026 earnings call because management plans to take investor questions for that later report. For the lidar developer, the key issue is whether commercial activity can translate into materially higher revenue while the company controls its cash use.

Q2 revenue improved as losses widened

MicroVision generated USD 1.473 million of revenue in Q2 2026, compared with USD 935,000 in Q1 2026. That represents a 57.5 percent sequential increase, although the company reported a consolidated net loss of USD 36.943 million in Q2 versus USD 25.294 million in Q1, according to Investing.com.

Investing.com reported that MicroVision maintained 2026 revenue guidance of USD 10 million to USD 16 million and ended Q2 with USD 27.2 million in cash. The same report cited a 44 percent gross margin and a plan to reduce cash burn in the second half as integration and restructuring costs fade.

MVIS remains near its yearly low

The October 5 quote stood USD 0.06 above the 52-week low of USD 1.40 and USD 21.64 below the 52-week high of USD 23.10. Trading volume had reached 320,416 shares by 1:19 p.m. ET, while the market capitalization stood at USD 34.1 million.

For investors, the October 7 discussion links the stock's near-term story to execution rather than a single product announcement. Revenue growth from USD 935,000 to USD 1.473 million is a measurable step, but the Q2 net loss of USD 36.943 million keeps cash discipline central to the outlook.